含组氨酸标签的甲/乙型流感嵌合体假病毒颗粒的构建和表达

为了获得内含甲/乙型流感病毒部分序列的病毒样颗粒,本研究通过定点突变技术将6个组氨酸插入MS2噬菌体包膜蛋白的β-发夹环结构中,建立通用表达载体D-pET32a-CP-his。并采用聚合酶链反应扩增甲/乙流病毒cDNA的部分保守区域,将两种病毒的嵌合体基因序列连接到表达载体,转化BL21细胞。经诱导表达和镍柱亲和层析纯化,获得了含有甲/乙型流感病毒部分序列的高浓度和纯度的病毒样颗粒。该病毒样颗粒在4℃和-20℃条件下可稳定保存。本研究构建带有组氨酸纯化标签假病毒的通用表达载体,可以作为以后构建和制备耐RNase的mRNA标准品和质控品的平台;构建的甲/乙型流感嵌合体假病毒可为实验室流感病毒的检测提供新的标准品及质控品。     

一种带有组氨酸标签的新型表达载体的构建及应用

目的:利用基因重组技术,对已有载体pSE380进行改造,获得具有组氨酸标签的新型表达载体.方法:以pSE380载体为出发材料,通过一步反向PCR技术在多克隆位点处添加一个六聚组氨酸纯化标签,并用该载体对xdh外源基因进行克隆表达及纯化验证.结果:测序结果显示该标签已成功插入,xdh基因克隆表达及纯化表明,镍柱亲和层析完全可以将重组的表达蛋白纯化,并达到电泳纯级别.融合标签并没有影响的该重组酶的功能.结论:通过一步反向PCR技术成功地获得了改造psE380载体,该技术为载体的相关改造提供了一种方便可行的方法.     

高效原核表达载体pBV220的改造与应用

以高效原核表达载体 pBV220为骨架载体,应用单链寡核苷酸引物插入法在pBV220多克隆位点的下游插入了六聚组氨酸融合标签编码序列(6×His-Tag)、羟胺和凝血酶蛋白切割位点, 并增加了Xho I和Kpn I酶切位点和强终止密码子TAA, 将此新质粒命名为 pBV223。以此载体表达的目的蛋白在羧基端(C端)带有六聚组氨酸尾以利于通过固定化金属亲和层析快速纯化目的蛋白, 酶切及核苷酸序列分析验证了我们的设计。将终止密码缺失突变的nm23-H1 cDNA克隆入pBV223载体中, 在大肠杆菌DH5a中成功地表达了Nm23-H1蛋白, 通过镍(Ni)亲和层析一步即简单、快速地得到了纯化蛋白。我们所应用的单链寡核苷酸引物插入直接进行定向克隆的方法是目前为止最简便的方法。     

应用改进的多聚组氨酸标签T7表达载体构建肺癌cDNA文库

应用噬菌体C端展示系统构建的cDNA文库缺乏开放阅读框筛选机制,文库中多数噬菌体克隆展示框外非天然短肽,给后期蛋白质的筛选带来了不便. 为实现噬菌体的ORF筛选功能,利用PCR技术对已有载体T7Select10-3b进行改造,在MCS处外源cDNA插入位点的3′端引入6聚组氨酸筛选标签,经包装后挑取成功表达的单克隆构建肺癌cDNA文库. 经镍柱亲和层析后,收集文库中表达组氨酸的克隆,利用化学发光免疫试验进行筛选效果鉴定. 结果显示,改造的新型载体可成功表达组氨酸标签,以此构建的肺癌cDNA文库经筛选后,含ORF插入的克隆由筛前的6 %提高至70 %,本研究为提高cDNA文库的质量提供了一种简便可行的方法.     

人酪氨酸蛋白激酶Lyn的真核表达、纯化及鉴定

[目的]构建含人酪氨酸蛋白激酶Lyn基因的载体并进行真核表达、纯化和研究其对细胞增殖的影响。[方法]提取人Hela细胞总RNA,用RT-PCR方法获得Lyn基因并克隆至pcDNA3.1(-)载体。经双酶切、PCR和测序方法鉴定后,将重组质粒瞬时转染HEK 293T细胞表达目的蛋白,应用组氨酸标签镍离子螯合磁珠纯化融合蛋白,通过Western Blot检测蛋白的表达及纯化,并用CCK-8法检测过表达Lyn后细胞增殖能力的变化。[结果]成功构建真核表达质粒pcDNA3.1(-)-Lyn并进行瞬时表达和蛋白纯化,CCK-8法检测过表达Lyn的HEK 293T细胞的增殖能力显著性下降(P0.01)。[结论]Lyn在HEK 293T细胞中成功瞬时表达及纯化,并可以使细胞的增殖能力受到明显抑制,为稳定表达和深入研究其生物学功能及作用机制奠定基础。     

人巨细胞病毒编码蛋白pUL23在E.coli BL21(DE3)中的表达和纯化

大肠杆菌中高效表达携带组氨酸标签的人巨细胞病毒皮层蛋白pUL23,并进行纯化以及鉴定.提取感染HCMV Towne病毒株的HFF细胞的总RNA,逆转录为cDNA作为模板,经PCR获得UL23的基因片段,将此片段插入表达载体pET-28a(+),构建pET28a(+)-UL23重组质粒.将pET28a(+)-UL23转化至大肠杆菌BL21( DE3),进行IPTG诱导表达.表达产物经Western blotting分析后进行发酵,再用Ni sepharose亲和层析纯化,纯化产物进行SDS-PAGE和Western blotting检测.结果表明,成功构建pET28a(+)-UL23原核表达载体,表达及纯化了His-pUL23融合蛋白.为进一步研究pUL23奠定基础.     

多聚组氨酸融合标签在蛋白药物开发中的应用

纯化技术是制约蛋白质药物开发及其产业化的关键技术之一。构建多聚组氨酸标签融合蛋白,采用固定金属离子亲和层析进行纯化,是一种高效的蛋白质纯化策略。介绍多聚组氨酸融合标签在蛋白质药物开发中的应用基础和应用概况,分析多聚组氨酸标签在融合蛋白中的位置对亲和层析纯化的影响,总结常用的多聚组氨酸融合表达方式,并对其融合表达样品的预处理、亲和层析纯化条件及其对目的蛋白药物药用安全性和有效性的影响进行探讨。     

乙型肝炎病毒DNA聚合酶反式调节蛋白HBVDNAPTP1的表达、纯化与初步鉴定

目的构建HBVDNAPTP1基因的原核表达载体,诱导其在大肠埃希菌中表达,并对融合蛋白进行纯化。方法利用逆转录-PCR获得乙型肝炎病毒(HBV)DNA聚合酶(Polymerase)反式调节人类新基因HBVD-NAPTP1,测序正确后插入至原核表达载体pET-32a(+)中,转化BL21(DE3)宿主菌进行诱导,并利用组氨酸亲和层析方法对融合蛋白进行纯化。结果 HBVDNAPTP1原核表达载体转化宿主菌后,经0.5 mmol/L IPTG、30℃诱导5 h获得了分子量约为31 kD的HBVDNAPTP1融合蛋白的优化表达,Western blotting证实融合蛋白的特异性。亲和层析纯化后得到较纯的HBVDNAPTP1融合蛋白,每升培养菌液中可获得2.24 mg的纯化蛋白。结论成功获得纯化的HBVDNAPTP1融合蛋白,为今后开展HBVDNAPTP1的生物学功能研究奠定了物质基础。     

纯化标签的不同位置对Δ6脂肪酸脱饱和酶异源表达的影响

【背景】目前利用酵母表达系统已鉴定了多种物种中的Δ6脂肪酸脱饱和酶(FADS6)。由于FADS6是一种具有多个跨膜螺旋的膜蛋白,使得其大量表达和纯化具有挑战性。【目的】探索FADS6的高效表达策略,研究纯化标签添加的位置对高山被孢霉FADS6I (Ma FADS6I)重组表达效率的影响。【方法】在毕赤酵母表达载体中插入串联亲和标签HRV 3C-Protein A-His,利用改造后的载体构建带有N端或C端标签的Ma FADS6I表达载体;通过电转化获得毕赤酵母重组表达菌株;利用斑点印迹杂交(DotBlot)、聚丙烯酰胺凝胶电泳(SDS-PolyacrylamideGelElectrophoresis,SDS-PAGE)和免疫印迹(Western Blot)分析重组蛋白的表达水平,并利用气相色谱-质谱(Gas Chromatography-Mass Spectrometry,GC-MS)分析检测Ma FADS6I催化生成的脂肪酸。【结果】通过大量的毕赤酵母转化子筛选,最终获得高效表达Ma FADS6I的毕赤酵母重组菌,证实各转化子的表达具有差异性,Ma FADS6I的C端带有纯化标签较N端更有利于表达。【结论】在Ma FADS6I的C端添加纯化标签比在N端添加更有利于该蛋白在酵母系统中的表达以及底物的转化,为进一步探究FADS6高效表达和结构功能奠定了基础。     

人Hepassocin的原核可溶性表达与纯化

目的：构建人Hepassocin的原核表达载体,可溶性表达并纯化得到高纯度的重组人Hepassocino方法：将人Hepassocin基因克隆到原核表达载体pET40b（＋）,转化大肠杆菌BL21（DE3）,于28℃经0．1mmol／LIPTG诱导6h,表达Ds-bC-Hepassocin融合蛋白,经镍柱纯化可溶性融合蛋白,用肠激酶切除融合蛋白的DsbC-His标签,再用镍柱纯化分离酶切后的Hepassocin,通过超滤进一步纯化并浓缩,用Western blot验证纯化后的Hepassocin。结果：构建了pET40b-Hepassocin原核表达载体,经诱导表达、亲和层析和肠激酶切除融合标签,获得了相对分子质量约32000的可溶性高纯度蛋白,Western blot鉴定证实该蛋白为不含融合标签的重组人Hepassocin。结论：实现了人Hepassocin的原核可溶性表达,通过纯化获得了较高纯度的重组人Hepassocin,为制备其单克隆抗体,进一步研究其生物学功能奠定了基础。     

Life cycle of the ichthyotoxic dinoflagellate Cochlodinium polykrikoides in Korean coastal waters

Since 1995, blooms of the harmful dinoflagellate, Cochlodinium polykrikoides, have caused considerable mortality of aquatic organisms and economic loss in Korea. However, little is known about the life cycle of the species, except for the planktonic vegetative stage; therefore, the aim of this paper was to elucidate the life cycle of C. polykrikoides. Its life cycle has two morphologically different stages: an armored and an unarmored vegetative stage. Armored vegetative cells were found in seawater samples collected in late-November and developed into four-cell chained, unarmored vegetative cells under laboratory culture. In samples collected in late-May, both the armored and unarmored types (vegetative swimming stage) occurred; the former easily developed into an unarmored vegetative cell type, suggesting that the armoured–unarmored transition occurs as early as May. A presumptive resting cyst, round but folded at one side, was produced from armored type cells in laboratory conditions. It was also collected from natural bottom sediments, which suggests it is the dormant resting cyst of C. polykrikoides.     

香茄环斑病毒HC—RT—PCR—ELISA检测

番茄环斑病毒（ToRSV)是我国对外检疫一类有害生物。目前国内尚无存在的报道。PCR技术是一种快速灵敏的植物病毒检测方法,但核酸内的聚合酶抑制物会导致漏检现象。而只通过凝胶电泳进行结果判定会出现假阳性,这两方面限制了PCR技术在对外检疫中的应用,利用共价结合在PCR管壁上的引物特异性杂交诱捕核酸粗提液中的靶标核酸,洗掉杂质及抑制物质,在同一管内作RT-PCR,凝胶电泳检测液相产物的同时对固相产物进行杂交检测。提高了结果的可靠性及灵敏度。利用所建立的HC-RT-PCR-ELISA成功地从法国进口葡萄苗中检出ToRSV。本方法可用于其他植物病毒及转基因产品的检测。     

SYNCRIP, a member of the heterogeneous nuclear ribonucleoprotein family, is involved in mouse hepatitis virus RNA synthesis

Several cellular proteins, including several heterogeneous nuclear ribonucleoproteins (hnRNPs), have been shown to function as regulatory factors for mouse hepatitis virus (MHV) RNA synthesis as a result of their binding to the 5' and 3' untranslated regions (UTRs) of the viral RNA. Here, we identified another cellular protein, p70, which has been shown by UV cross-linking to bind both the positive- and negative-strand UTRs of MHV RNA specifically. We purified p70 with a a one-step RNA affinity purification procedure with the biotin-labeled 5'-UTR. Matrix-assisted laser desorption ionization (MALDI)-mass spectrometry identified it as synaptotagmin-binding cytoplasmic RNA-interacting protein (SYNCRIP). SYNCRIP is a member of the hnRNP family and localizes largely in the cytoplasm. The p70 was cross-linked to the MHV positive- or negative-strand UTR in vitro and in vivo. The bacterially expressed SYNCRIP was also able to bind to the 5'-UTR of both strands. The SYNCRIP-binding site was mapped to the leader sequence of the 5'-UTR, requiring the UCUAA repeat sequence. To investigate the functional significance of SYNCRIP in MHV replication, we expressed a full-length or a C-terminally truncated form of SYNCRIP in mammalian cells expressing the MHV receptor. The overexpression of either form of SYNCRIP inhibited syncytium formation induced by MHV infection. Furthermore, downregulation of the endogenous SYNCRIP with a specific short interfering RNA delayed MHV RNA synthesis; in contrast, overexpression or downregulation of SYNCRIP did not affect MHV translation. These results suggest that SYNCRIP may be directly involved in MHV RNA replication as a positive regulator. This study identified an additional cellular hnRNP as an MHV RNA-binding protein potentially involved in viral RNA synthesis.     

Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges

In a recent vaccine trial, we showed efficient control of a virulent simian-human immunodeficiency virus SHIV-89.6P challenge by priming with a Gag-Pol-Env-expressing DNA and boosting with a Gag-Pol-Env- expressing recombinant-modified vaccinia virus Ankara. Here we show that long-term control has been associated with slowly declining levels of viral RNA and DNA. In the vaccinated animals both viral DNA and RNA underwent an initial rapid decay, which was followed by a lower decay rate. Between 12 and 70 weeks postchallenge, the low decay rates have had half-lives of about 20 weeks for viral RNA in plasma and viral DNA in peripheral blood mononuclear cells and lymph nodes. In vaccinated animals the viral DNA has been mostly unintegrated and has appeared to be largely nonfunctional as evidenced by a poor ability to recover infectious virus in cocultivation assays, even after CD8 depletion. In contrast, in control animals, which have died, viral DNA was mostly integrated and a larger proportion appeared to be functional as evidenced by the recovery of infectious virus. Thus, to date, control of the challenge infection has appeared to improve with time, with the decay rates for viral DNA being at the lower end of values reported for patients on highly active antiretroviral therapy.     

RNA‐Directed rna polymerases of plants

The report in 1971 by Comuet and Astier‐Manifacier that Chinese cabbage contains an active RNA‐dependent RNA polymerase has been extended to all plants studied. This has met with much opposition because the central dogma of molecular biology requires no replication mechanism for RNA. Only upon RNA virus infection are such enzymes needed, and it was generally believed that these were always and only virus‐coded. The purification and characterization of several of these plant viruses will be reviewed, with particular reference to the fact that while their amount in plant tissue is variably increased by various RNA virus infections their nature is unaffected by the viral genome and is strictly host‐specific. It will be noted, however, that in a specific instance viral infection has been shown to affect an important property of the enzyme. Also, it has become evident that certain plant viruses resemble animal picorna viruses (e.g., polio virus) and that these viruses carry an RNA polymerase gene. The same may be true, but has not been proven, for a small group of plant viruses that shows resemblances to the prokaryotic RNA phages in which a viral gene product together with host proteins form the RNA polymerase. An important question that remains to be solved in future work is the role of RNA polymerases in normal plant cell biology. Also, the mechanism by which viral infection causes the enzyme to become largely membrane or organelle bound and possibly conformationally changed in the process remains to be elucidated.     

Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays

The 2013-present Ebola virus outbreak in Western Africa has prompted the production of many diagnostic assays, mostly based on nucleic acid amplification technologies (NAT). The calibration and performance assessment of established assays and those under evaluation requires reference materials that can be used in parallel with the clinical sample to standardise or control for every step of the procedure, from extraction to the final qualitative/quantitative result. We have developed safe and stable Ebola virus RNA reference materials by encapsidating anti sense viral RNA into HIV-1-like particles. The lentiviral particles are replication-deficient and non-infectious due to the lack of HIV-1 genes and Envelope protein. Ebola virus genes were subcloned for encapsidation into two lentiviral preparations, one containing NP-VP35-GP and the other VP40 and L RNA. Each reference material was formulated as a high-titre standard for use as a calibrator for secondary or internal standards, and a 10,000-fold lower titre preparation to serve as an in-run control. The preparations have been freeze-dried to maximise stability. These HIV-Ebola virus RNA reference materials were suitable for use with in-house and commercial quantitative RT-PCR assays and with digital RT-PCR. The HIV-Ebola virus RNA reference materials are stable at up to 37°C for two weeks, allowing the shipment of the material worldwide at ambient temperature. These results support further evaluation of the HIV-Ebola virus RNA reference materials as part of an International collaborative study for the establishment of the 1^st International Standard for Ebola virus RNA.